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cense.Abstract Background: Oncoplastic breast conservative surgery has evolved as a safe alternative to
the standard mastectomy in the treatment of early breast cancer. The procedure involves tumour
resection with an adequate safety margin and either breast reshaping with volume displacement pro-
cedures (large or ptotic breasts) or volume replacement with latissimus dorsi myocutaneous ﬂap
(LDF) (small to medium sized non-ptotic breasts). A contra lateral mastopexy procedure is usually
necessary with the volume displacement oncoplastic surgery, a procedure that is often rejected by a
signiﬁcant number of patients. This limits the choice of the reconstruction of breast defects in such
patients to autologous tissues i.e. LDF.
Aim: Aim is to evaluate the feasibility of volume replacement oncoplastic breast conservative sur-
gery with latissimus dorsi myocutaneous ﬂaps for patients with large ptotic breasts. This involves
testing the oncologic safety in terms of adequate safety margin, the complications rate and the ﬁnal
cosmetic outcome. The loco regional recurrence rate will be recorded and compared with oncoplas-
tic volume displacement for similar sized breast defects.
Patients and methods: A group of 50 female patients with early breast cancers (T2) who presented
to the department of surgery at the National Cancer Institute, Cairo, Egypt in the period between
January 2004 and November 2009 were included in the study. Bilateral soft tissue mammography.uk (H.H. El-Marakby).
Institute, Cairo University.
.
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164 H.H. El-Marakby, M.H. Kotbwas carried out in all patient groups and was used to annually follow up the patients. All patients
were detected with T2 N0 breast cancer by both clinical and radiological examinations. All patients
underwent partial mastectomy and reconstruction with LDFs.
Results: The average age at presentation was 46.5 ± 9 years and the range was 26–65 years. Most
of the patients were subjected to partial mastectomy in 30 patients (60%), excision of a single quad-
rant from the four major quadrants was carried out in 15 patients (30%) where skin sparing wide
local excision was carried out in only ﬁve patients (10%). The safety margin ranged from 1.1 to
3.2 cm with an average of 1.8 ± 0.5 cm. There was no total ﬂap loss in any patient where as we
reported partial ﬂap loss in two patients. Nipple and areola sloughing were reported in two patients,
wound infection in ﬁve patients, haematoma in four patients, seroma in 16 patients, and donor site
morbidity in six patients. The vast majority of patients were either satisﬁed (score >3 out of 5)
(62%) or very satisﬁed (score 4 or more) (18%) with the results of reconstruction.
Conclusion: The results of the current study showed the feasibility and the versatility of volume
replacement oncoplastic surgery in patients with large ptotic breasts with myocutaneous ﬂaps.
The adequacy of safety margin and the acceptable complications rate as well as the comparable
local recurrence rate to volume displacement oncoplastic surgery, make it a suitable alternative
in a subset of patients who object an immediate contra lateral mastopexy procedure.
ª 2011 National Cancer Institute, Cairo University. Production and hosting by Elsevier B.V.
Open access under CC BY-NC-ND license.Introduction
Until recently, the surgical management of breast cancer has
been based on two main options; either tumour resection with
safety margin (breast-conserving surgery) (BCS) or the stan-
dard mastectomy with or without reconstruction [1]. Breast
conserving treatment (BCT) combined with radiotherapy has
stood the test of time as a sound oncological treatment regard-
ing survival and local recurrence rates. Successful BCT
requires a balance between adequate surgery and maintaining
the breast’s appearance. Nonetheless, unsatisfactory aesthetic
outcome reaches 20–30% in the standard techniques of BCS
[2].
The extent of local excision remains a controversial issue in
breast-conserving surgery. The wider the margins of clearance,
the lower the risk of local recurrences, but higher the risk of
visible deformity leading to unacceptable cosmetic results [3].
Type-1 breast deformity CS1 is deﬁned as an asymmetry be-
tween the two breasts, with no distortion or deformity of the
radiated breast. Type-2 CS is an obvious breast deformity that
can be corrected with partial reconstruction of the breast.
Type-3 CS is such deformity that only a mastectomy with total
reconstruction of the breast can be performed. Most of the
patients present with type-2 CS, but are reluctant to undergo
what they feel is a major reconstructive procedure [4].
For type-1 deformities, surgery to the irradiated breast
should be avoided when possible. Type-2 deformities raise
the most difﬁcult therapeutic problems because they are
mainly postoperative complications that could have been pre-
vented by performing immediate remodelling of the treated
breast before radiotherapy. This demands the integration of
plastic surgical techniques at the time of the original lumpec-
tomy, thus reducing the need for delayed reconstructive
surgery [5].
In one series of patients with BCT, 56.5% of the deformities
were type-1 cosmetic sequelae (CS1) and 38.8% were type-2
CS and 4.7% were type-3 CS. Type-1 patients should be man-
aged essentially by contra lateral symmetrising procedures.
Type-2 was the most difﬁcult to manage and required all thetechniques of breast reconstructive surgery. The insetting of
a myocutaneous ﬂap was often necessary and autologous fat
grafting was a promising tool in selected cases. Type-3 CS re-
quired mastectomy and immediate reconstruction with a myo-
cutaneous ﬂap [4]. In another series of patients, following BCT
33% had a type-1 deformity; all but one patient was treated
with contra lateral mammaplasty. 42% had a type-2 deformity
and were treated by various techniques (implant, mamma-
plasty, latissimus dorsi ﬂap, or transverse rectus abdominis
musculocutaneous ﬂap). Only 43.8% of patients in this group
had a late satisfactory cosmetic result [5].
Lately, techniques that combine the skills of resection with
those of reconstruction in one procedure have lead to the
development of oncoplastic breast-conserving reconstruction.
This approach involves reconstruction of resection defects
either by volume replacement or by volume displacement.
Both techniques are adaptations of conventional methods of
breast reconstruction or breast reduction mammoplasty [1].
Concepts described have widened the spectrum of BCT, and
have made an improvement of cosmetic outcome, and facili-
tated a liberal safety margin. Volume displacement techniques,
such as glandular ﬂap, mammoplasty, donut mastopexy, and
batwing mastopexy proved useful in large breasts. On the
other hand volume replacement, such as latissimus dorsi ﬂap
and local ﬂaps are of great advantage to replace defects in
small and medium sized non-ptotic breasts [2].
Oncoplastic surgical resection is designed to follow the can-
cer’s contour, which generally follows the segmental anatomy
of the breast. With negative surgical margins, the lumpectomy
is equivalent to the quadrantectomy in achieving the goals of
breast conservation as measured by local recurrence and
survival. However, the lumpectomy is less versatile for resec-
tion of larger cancers, and can be more prone to creating sub-
optimal cosmetic defects [6]. Oncoplastic surgery achieves
more accurate tumour resection than standard quadrantecto-
my with no reconstruction. In a recent study the median vol-
ume of the excised specimen in the oncoplastic volume
displacement group was found to be larger than in the quad-
rantectomy group without volume replacement. The nearest
Figure 1b Type-2 deformity: A defect in the upper outer
quadrant of the breast that could have been prevented with LD
mini ﬂap.
Figure 1a Type one deformity: slight asymmetry that can be
corrected by a contra lateral mastopexy.
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in the quadrantectomy group [7].
Partial mastectomy and immediate reconstruction with a
myocutaneous latissimus dorsi ﬂap allows more extensive
resection, which ﬁts oncologic requirements, without serious
morbidity and a good cosmetic outcome. In a recent study
the free margins were obtained in all cases and the cosmetic
outcome was found to be good in 44% of the cases and satis-
factory in the remaining 56%. Symmetry and the scar of the
reconstructed breast were the most inﬂuential criteria in the
quantitative assessment of overall cosmetic results [8].
Latissimus dorsi miniﬂaps can be also used to reconstruct
central and upper quadrant resection defects, replacing the vol-
ume excised with autogenous tissue. Partial mastectomy, axil-
lary dissection, ﬂap harvest and reconstruction of the resection
defect are performed as a one-stage procedure through a single
lateral incision. This oncoplastic approach particularly with
central defects, allows extensive local excision during BCS
without cosmetic penalties in a group of patients normally
treated by mastectomy [9]. The extended LDF has made the
reconstruction of relatively large breast defects even more
feasible. This was found to be beneﬁcial in treating large T2
breast cancer by BCS. This did not demand any implant inser-
tion to supplement the volume restoration with extended LDF
in all cases [10].
This prospective study was undertaken to evaluate the
accuracy of breast tumour resection and the lateral margin
in a group of patients with large ptotic breasts who under-
went oncoplastic breast conservative surgery and volume
replacement with LDF. The ﬁnal cosmetic results after com-
pleting the radiotherapy treatment were evaluated. The late
follow up and the rate of loco regional recurrence was also
assessed.
Patient and methods
A group of 50 female patients with early breast cancers (T2)
presented to the Department of Surgery at the National Can-
cer Institute, Cairo, Egypt presented between January 2004
and November 2009 were included in the study. All patients
were T2 N0 breast cancer by both clinical and radiological
examination. All patients underwent routine laboratory inves-
tigations including complete blood count, liver and kidney
functions as well as chest X ray. The staging process was based
on carrying out routine digital mammography complemented
with an ultrasound examination to both breasts and the axilla.
Histopathological examination was performed through a free
hand core biopsy for superﬁcial tumours and an ultrasound
guided biopsy for deeply seated tumours. The inclusion criteria
included tumour sizes up to 4 cm in maximal diameter with N0
axilla. Breast size was taken into consideration and patients’
moderate or large ptotic breasts were counselled with regards
to performing breast reshaping with one of the volume dis-
placement procedures. Patients who rejected the option of
immediate contra lateral breast surgery were given the option
to go through breast conservative surgery and an immediate
augmentation mammoplasty with one of the LDFs. Types of
breast deformities if the reconstruction were not to be per-
formed were mentioned to the patients and photographs of
each were provided and viewed by the patients themselves as
well as their partners (Fig. 1).All patients who elected to go through the operation of an
augmentation mammoplasty with one of the LDFs were
consented for this option. The potential complications of the
procedure such as ﬂap necrosis, haematoma, infection, and
seroma as well as donor site morbidity were discussed with
the patients. Further surgery to treat such complications as
well as late auxiliary surgery to achieve the maximal symmetry
was also discussed.
The ﬁnal aesthetic results were evaluated after completion
of the BCT. The evaluation parameters included the breast
shape, volume, projection and the nipple and areola symmetry.
A score of 1–4 (poor, fair, good, and very good or excellent)
was given by 2 independent observers, none of whom was in-
volved in the surgical procedure. A similar score was given
to the patients themselves (1–4) (not satisﬁed, fairly satisﬁed,
satisﬁed, and very satisﬁed).
Results
Fifty female patients with early breast cancer (T2) who under-
went oncoplastic breast conservative surgery with volume
replacement LDF were evaluated. All patients had a moderate
to large ptotic breasts and rejected volume displacement com-
bined with contra lateral breast mastopexy procedures as a
Table 2 Type of surgery performed and complications rate in
the study group (50 patients).
Type of
surgery
Patients
(No. and %)
Complications
(No. and %)
Quadrantectomy +
LDF
15 (30%) 3 (6)
Partial mastectomy +
extended LDF
30 (60%) 5 (10)
Skin sparing wide local excision +
mini LDF
5 (10%) 1 (2)
Table 1 Tumour size, site, safety margin and lymph node
status in 50 breast cancer patients.
Tumour parameters Number Percentage
Largest diameter
2.5–2.9 cm 5 10
3.0–3.5 cm 16 32
3.6–4.0 cm 29 68
Tumour site
Upper outer 31 62
Upper inner 4 8
Lower outer 4 8
Lower inner 6 12
Central 5 10
Safety margin
1.0–1.5 cm 32 64
1.6–2.0 cm 10 20
>2.0 cm 8 16
Lymph nodes metastasis
None 40 80
1–3 lymph node 8 16
>3 lymph node 2 4
Figure 2 Quadrantectomy and a standard latissimus myocuta-
neous ﬂap (score = 4).
Figure 3 Skin sparing wide local excision and LD miniﬂap
(score = 4).
Figure 4 Central mastectomy and extended latissimus ﬂap
reconstruction (score = 3).
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tion of cancer. The average age at presentation was
46.5 ± 9 years and the range was 26–65 years. The average
follow up period was 33 ± 9 months and the range was 20–
54 months. All patients were T2 (tumour more than 2.5 cm
in largest diameter) and N0 where no clinically palpable lymph
node could be detected (Table 1).
Most of the patients were subjected to partial mastectomy
(30) (60%), Excision of a single quadrant from the major four
quadrants (upper outer, lower outer, upper inner, and lower
inner) was carried out in 15 (30%) of patients while skin
sparing wide local excision was carried out in only 5 (10%)
of patients (Table 2). The defects were upper outer in 62%,
upper inner in 8%, central in 20% and inferior defects in
20% of cases.
All the patients who underwent quadrantectomy or partial
mastectomy operation required an augmentation mammo-
plasty operation to restore the breast volume with the standard
latissimus dorsi myocutaneous ﬂap (90%), and the rest were
reconstructed with LD miniﬂap (10%) (Table 2 and Figs. 1–4).
There was no total ﬂap loss in any patient where we re-
ported partial ﬂap loss in two patients. Nipple and areola
sloughing were reported in two patients, wound infection [5],
haematoma [4], and donor site morbidity in six patients in
the form of wound infection, partial wound disruption, haema-toma; and late hypertrophic scaring in two patients. Seroma in
the breast or the axilla were reported in 10 patients and in the
donor site in six patients.
Histopathological assessment revealed that the average size
of the resected tumour was 3.5 · 2.8 · 2 cm when measured
grossly. The safety margin ranged from 1.1 to 3.2 cm with a
mean of 1.8 ± 0.5 cm. Pathologically affected axillary lymph
nodes were reported in only 20% of patients. Most of the in-
volved lymph nodes were less than three in number (80%) with
only two cases showing capsular rupture. With regards to the
histology of the disease we found out that most of these were
Table 3 Final assessment of cosmetic results after completion
of treatment by two independent observers in 50 patients.
Final score Number (n= 50) Percentage (%)
Poor (score <3) 2 4
Fair (score 3) 3 6
Good (3–4) 30 60
Very good (score >4) 15 30
Table 4 Assessment of the results of reconstruction (patients’
assessment).
Final score Number (n= 50) Percentage (%)
Not satisﬁed 5 10
Fairly satisﬁed 5 10
Satisﬁed 31 62
Very satisﬁed 9 18
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cinoma (82%). Lobular carcinoma was only detected in 10%
of cases. The majority of the disease was grade two (80%)
where the rest was either grade one (6%) or three (14%).
The vast majority of our patients received postoperative
radiation therapy (92%), and 86% received chemotherapy
and the indications were tumours more than 2 cm, receptor
negative, higher grade of the disease, nodes positive, capsular
rupture, and young age <40 years at presentation. Hormonal
treatment was required in 74% of cases for those who
conﬁrmed to be ER or PR positive in histological examination
or the resected specimens.
During the follow up period we detected only two local
recurrences and 1 distant metastasis (bone). Fat necrosis was
reported in six patients (12%) all required surgical intervention
after radiological and histological assessment to conﬁrm the
diagnosis.
The ﬁnal aesthetic assessment showed that the vast majority
of patients were either satisﬁed (score 3 out of 5 or more)
(62%) or very satisﬁed (score 4 or more) (18%) with the results
of reconstruction. Those who were not satisﬁed or fairly satis-
ﬁed were those who suffered some complications that affected
the breast volume, projection or symmetry with the contra lat-
eral side (Table 4).
The patient expectations have matched independent assess-
ment where the observers thought that the majority of the re-
sults were either good (60%) or very good (30%). This was
based on comparing breast volume, projection, symmetry and
nipple and areola shape with the contra lateral side (Table 3).
Discussion
The term oncoplastic surgery refers to surgical techniques on
the basis of oncological principles during which the plastic
surgery techniques are used, mostly for reconstructive and cos-
metic purposes. Oncoplastic breast conservative surgery is a
broad concept that comprises several different combinations
of oncological surgery and plastic surgical procedures: Volume
displacement involves excision of the tumour using reduction
mammoplasty techniques, or tumour excision followed by
remodelling mammoplasty. Volume replacement involves par-tial mastectomy with immediate reconstruction of the breast
with prosthesis or one of the LD ﬂaps. The advantage of the
oncoplastic surgery for breast cancer is the possibility of per-
forming a wider excision of the tumour with immediate breast
reconstruction aiming at good cosmetic results [11].
Trends in the management of unilateral breast cancer from
delayed to immediate reconstruction and from implants to
autologous tissue have reduced the incidence of contra lateral
symmetrisation procedures. Reduction mammoplasty is the
most common symmetry procedure used for autologous tissue
reconstruction [12].
Attempting breast-conserving surgery in patients with large
breasts carries many challenges related to the varieties of
defects and their anatomical sites. Partial mastectomy defects
can be usually reconstructed by volume displacement, recruit-
ing and transposing local glandular or dermoglandular ﬂaps
into the resection site, or less commonly by volume replace-
ment, importing volume from elsewhere to replace the amount
of tissue resected [3].
Cultural issues in relation to patient selection and thereby
the indications of each technique have not been sufﬁciently ad-
dressed in the literature. In the Egyptian culture most women
decline contra lateral breast surgery, a procedure that is con-
sidered necessary to achieve an acceptable symmetry with vol-
ume displacement oncoplastic surgery. The majority,
regardless and irrespective to the size of the breast or the
degree of ptosis, prefer an augmentation mammoplasty proce-
dure based on autologous tissue reconstruction rather than a
contra lateral mastopexy. This means that some patients who
could have beneﬁted from oncoplastic volume displacement
have preferred the option of volume replacement by autolo-
gous breast reconstruction.
In the current study we tested the feasibility of oncoplastic
breast conservative surgery with volume replacement in
patients with large ptotic breasts. This is contrary to its
original indication in the literature i.e. small to medium sized
non-ptotic breasts. There were three main parameters of
assessment; the adequacy of safety margins, the complications
rate, and the ﬁnal cosmetic results.
The safety margin was satisfactory in all of our patients
(1.8 ± 0.5 cm) with no single case that required further exci-
sion matching the reported studies of volume replacement
for a variety of breast defects [9,10,13]. The results were even
better than the reported studies of oncoplastic volume dis-
placement [14], where a close or involved margin in that study
were reported in 18.9%, with mastectomy being necessary in
9.4%.
Latissimus dorsi miniﬂaps can be also used to reconstruct
central and upper quadrant resection defects, replacing the
volume excised with autogenous tissue. Partial mastectomy,
axillary dissection, ﬂap harvest and reconstruction of the resec-
tion defect are performed as a one-stage procedure through a
single lateral incision. This oncoplastic approach particularly
with central defects, allows extensive local excision during
BCS without cosmetic penalties in a group of patients nor-
mally treated by mastectomy [9]. The extended LDF had made
the reconstruction of relatively large breast defects even more
feasible. This was found to be beneﬁcial in treating large T2
breast cancer by BCS and this did not demand any implant
insertion to supplement the volume restoration with extended
LDF in all cases [10]. In the current study the standard latiss-
imus myocutaneous ﬂap was used to ﬁll defects following
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latissimus myocutaneous ﬂap was required for more extensive
defects following partial mastectomies where more than one
quadrant was excised (60%) (Fig. 4). The LD mini ﬂap was
only required for defects following non-anatomical skin spar-
ing wide local excision, such as for deeply seated lesions
(10%) where the skin envelope was preserved (Fig. 3).
Partial mastectomy and immediate reconstruction with a
myocutaneous latissimus dorsi ﬂap allows more extensive
resection, which fulﬁls oncologic requirements, without serious
morbidity and a good cosmetic outcome [8]. The complications
rate of the current study was 18% and that was very acceptable
compared to reported studies [8,10] where complications were
reported in 38% and 48% of their patients respectively. How-
ever, we also reported an incidence of seroma in 20% of cases
in the breast and in 12% of cases in the donor site; both were
treated conservatively with repeated aspiration. We also
reported an incidence of 12% of minimal fat necrosis that
was excised under local anaesthesia and resolved over the per-
iod of follow up with no signiﬁcant effect on the breast size,
shape or contour.
Highly satisfactory cosmetic outcomes extend the indica-
tions for conservative surgery, and further reduce the mastec-
tomy rate [13,15]. In the present study a satisfactory or very
satisfactory aesthetic outcome was obtained in 90% of our
patients. In spite of the relatively short follow up period, this
was comparable to other studies where 5 years satisfactory aes-
thetic results were reported in 80–90% of cases [8,14]. More-
over there was an agreement between the observers who
reported good or very good results in 90% of patients. The
views were aided by a photographic study in the assessment
of the LDF reconstruction; however, all evaluations remain
subjective, and objective assessment of the results especially
the degree of regaining a normal nipple sensation is recom-
mended. Also the long term psychological evaluation of the
long term results could be useful in determining the psycholog-
ical advantages and the degree of satisfaction after such
procedure.
In a study involving a larger series of patients the ﬁve-year
overall and the disease-free survival rates were 93% and 88%,
respectively, with a local recurrence rate of 7% [18]. We
reported only two cases (4%) of local recurrence and one case
of distant metastasis (2%) over the period of follow up. The
results of this series ensure the safety of oncoplastic breast sur-
gery for tumours both high in volume and difﬁcult in location.
However, a larger series of patients and a longer follow up
would be required to conﬁrm the signiﬁcance of such results.
Advanced volume–displacement techniques, which are
based on the key principles of breast reductive surgery, can
greatly increase the options for breast conservation in complex
cancer cases [14]. However, detailed studies are small and out-
come measures vary [16]. More over, these techniques require
detailed assessment of the oncological and cosmetic outcomes
and long-term results in comparison to volume replacement
procedures for a variety of breast defects and with different
breast sizes. On the other hand cancers with large in situ com-
ponents can be particularly problematic during resection with
the standard lumpectomy, when they extend both centrally
toward the nipple and peripherally to distal terminal ductu-
lo-lobular units. Ductal segments, each of which ultimately
drains to a single major lactiferous sinus at the nipple, vary
in size and depth in the breast [6,13,15]. Those tumours withsegmental spreading would need an extensive resection and
are best excised by oncoplastic techniques according to their
distribution and reconstruction with volume replacement by
autologous tissues.
In conclusion, oncoplastic approach will be an integral ele-
ment of the surgical treatment of breast cancer in the future.
The choice between volume displacement and volume replace-
ment autologous reconstruction must consider patients prefer-
ence after proper counselling. Cultural backgrounds should be
considered and patient involvement in the decision of which
oncoplastic procedure to select, is fundamental. The results
of the current study show that volume replacement with autol-
ogous tissues i.e. LDF can be a suitable alternative to volume
displacement in patients with large ptotic breasts, particularly
if they object to a combination of volume displacement with
immediate contra lateral breast mastopexy.References
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